Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 1.11B P/E - EPS this Y 24.90% Ern Qtrly Grth -
Income -167.48M Forward P/E -5.49 EPS next Y -1.70% 50D Avg Chg 2.00%
Sales 8.19M PEG - EPS past 5Y - 200D Avg Chg -25.00%
Dividend N/A Price/Book 3.13 EPS next 5Y - 52W High Chg -55.00%
Recommedations 1.90 Quick Ratio 3.96 Shares Outstanding 98.31M 52W Low Chg 18.00%
Insider Own 19.60% ROA -42.22% Shares Float 60.10M Beta -1.52
Inst Own 87.02% ROE -45.71% Shares Shorted/Prior 15.10M/13.57M Price 12.80
Gross Margin 91.37% Profit Margin - Avg. Volume 1,224,093 Target Price 39.25
Oper. Margin -1,401.45% Earnings Date - Volume 994,626 Change -4.12%
About Day One Biopharmaceuticals, Inc

Day One Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops and commercializes targeted therapies for patients with genomically defined cancers. Its lead product candidate is tovorafenib, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric patients with relapsed/ refractory low-grade glioma. The company is also developing Pimasertib, an oral small molecule inhibitor of mitogen-activated protein kinase kinases 1 and 2. Day One Biopharmaceuticals, Inc. was incorporated in 2018 and is headquartered in Brisbane, California.

Day One Biopharmaceuticals, Inc News
11/20/24 Day One Announces Retirement of Dr. Samuel Blackman, Co-Founder and Head of Research & Development
11/18/24 Day One to Participate in the Piper Sandler 36th Annual Healthcare Conference
11/06/24 Wall Street Analysts See a 136.83% Upside in Day One Biopharmaceuticals (DAWN): Can the Stock Really Move This High?
11/06/24 Exploring Three High Growth Tech Stocks in the United States
11/04/24 Bullish: Analysts Just Made A Huge Upgrade To Their Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) Forecasts
11/01/24 We Think Day One Biopharmaceuticals (NASDAQ:DAWN) Can Easily Afford To Drive Business Growth
10/30/24 Day One Biopharmaceuticals, Inc. (DAWN) Surpasses Q3 Earnings and Revenue Estimates
10/30/24 Day One Reports Third Quarter 2024 Financial Results and Corporate Progress
08:55 AM Wall Street Analysts Think Day One Biopharmaceuticals (DAWN) Could Surge 140.71%: Read This Before Placing a Bet
10/16/24 Day One Biopharmaceuticals (DAWN): Advancing Targeted Therapies for Pediatric Glioma
10/16/24 Day One to Report Third Quarter 2024 Financial Results Wednesday, October 30, 2024
10/01/24 At What Oil Price Will Shale Drillers Stop Drilling?
08/27/24 Taylor Fritz’s Girlfriend Morgan Riddle Opts for Classic Little Black Dress on Day One of the U.S. Open 2024
08/19/24 Jeff Bezos Said 'I Predict One Day Amazon Will Fail' And Claims Large Companies Only Last '30-Plus Years' – Guess How Old Amazon Is?
08/16/24 A great week that adds to Day One Biopharmaceuticals, Inc.'s (NASDAQ:DAWN) one-year returns, institutional investors who own 56% must be happy
08/14/24 Bank of America Says Buy These 3 Stocks for a Double-Digit Rally
08/07/24 Dow Jones Futures Fuel New Market Rally On Bank Of Japan; Nvidia Partner Super Micro Dives
07/30/24 Day One Biopharmaceuticals, Inc. (DAWN) Reports Q2 Loss, Tops Revenue Estimates
07/30/24 Day One Reports Second Quarter 2024 Financial Results and Corporate Progress
07/30/24 Day One Announces Oversubscribed $175.0 Million Private Placement
DAWN Chatroom

User Image Quantumup Posted - 17 hours ago

$DAWN ICYDK (No PR AFAIK) $DAWN has Three Tovorafenib Presentations for the Upcoming 29th Annual Meeting and Education Day of the Society for Neuro-Oncology November 21-24, 2024 in Houston, TX. #SNO2024 https://virtual.oxfordabstracts.com/event/18018/submission/175 https://virtual.oxfordabstracts.com/event/18018/submission/198 https://virtual.oxfordabstracts.com/event/18018/submission/125 $eras

User Image CH_Expat Posted - 18 hours ago

$DAWN $IDYA $ARVN Current Top-3 of my undervalued underperformers in Bioland. Missed the XBI-Run from 60 to 100 completely. Huge potential for doubles here.

User Image Luka_Law Posted - 19 hours ago

$KNSA $DAWN LFG, expected this to move higher. Also, your thoughts on MYNZ? Who's behind the 30M share offering deal? 👀 And how could the Thermo Fisher (TMO) partnership ($210B market cap) reflect this stock movement and PR buzz everywhere on socials?

User Image MoneyWise13 Posted - 1 day ago

$DAWN Such an easy buy and hold at these levels with initial sales figures coming in the way they have. Regardless of RFK, this is a clear BO play

User Image Paddy444 Posted - 1 day ago

$DAWN I have found major value here to come even in the short term. I also feel lots was accomplished in Europe. I now have a strong position here and feel this is where the value will really pay off with some patience now.

User Image DonCorleone77 Posted - 1 day ago

$NXE $OPRA $GFL $MGNI $DAWN This is in relation to the news I referenced in my post below on 10/25/24: NexGen Energy achieves permitting milestone NexGen Energy announced a milestone in the Federal EA process for its 100% owned Rook I Project. The CNSC has provided NexGen formal confirmation that the company has successfully addressed all information requests received as part of the Federal technical review. With completion of the CNSC technical review, the next and final steps in the federal approval process include scheduling a Commission Hearing Date for the Project, subject to which the CNSC will render an approval decision on the project.

User Image Polip Posted - 2 days ago

$DAWN someone here was over leveraged and is unwinding the position against its will. I can’t see why would anyone sane would sell at the current price

User Image G101SPM Posted - 2 days ago

$DAWN $13.02 bid. DAC (dollar average cost) (2) $14.22 last $13.39 (11.15.24). EXIT $30.00 - long term. BRIEF: Today announced that management will participate in a fireside chat at the Piper Sandler 36th Annual Healthcare Conference on Tuesday, December 3 at 3:00 p.m. EST.

User Image MoneyWise13 Posted - 2 days ago

$DAWN Really did not expect the RFK announcement to hit Bio's this hard. Great opportunity to add more here

User Image Dr_Van_Nostrend Posted - 2 days ago

$DAWN Sold puts here and added calls as well. They have over $8 a share in cash. It's pretty absurd to be down here after an extremely successful drug launch with triple the guided growth.

User Image Idvst8 Posted - 2 days ago

$DAWN - Cheap getting cheaper. Unreal.

User Image Quantumup Posted - 2 days ago

Jefferies initiated Erasca Inc ( $ERAS) at a Buy rating and a $6 price target. Jefferies told investors in its research note: "We see appeal in $ERAS's valuation supported by early but pot'ly best-in-class pan-RAS and pan-KRAS-targeted txs, given the massive market opty ( $RVMD mkt cap of ~$9B) and derisked MOA, based on data from $RVMD's RMC-6236. Add'ly, $ERAS preclin data look promising and are on-par/better than RMC-6236. ERAS is also in ph.III NRASmut melanoma w/ naporafenib + trametinib; although mkt opty could be smaller vs RAS, the study is derisked given prior ph.I&Il data." $nvs $mrk $dawn

User Image Night_Owl_Biotech Posted - 5 days ago

Earnings season is now over. Attached is a schedule noting actual Q3 v consensus for 64 of the 94 commercial-stage bios with a 1st/2nd product approved since 1/1/17 (market cap $200MM+) as well as changes in market cap (sorted high to low) since the start of earnings season. $RIGL was the biggest winner during this period. RIGL beat by 32% yet jumped 68%. $MDGL was #2 beating by 83% yet SP gains were 33%. $PHAT the biggest loser by, as best we can tell, warning of 2 years patent loss. $LXRX losses were not sales related. There were some real head scratchers especially in oncology including IOVA, $DAWN & GERN. We'll post simple analytics this weekend. This is not investment advice. We track these manually so there may be inadvertent mistakes.

User Image MoneyWise13 Posted - 5 days ago

$DAWN This is insanely overdone. M&A environment to improve under Trump while RFK takes control of drug industry. Definitely a double edge sword here, but this move lower is unwarranted. I'll be loading more Monday

User Image G101SPM Posted - 5 days ago

$DAWN $13.39 ask. BUY/ADD TO LONBG POSITION carries SPM 87.84 tag to $30.00 in long term. DAC (dollar average cost) (2) $$14.22..

User Image Smatty Posted - 6 days ago

$DAWN They are trying to drive this down on pretty nominal shares last few days. Don't let them steal yours.... Every target out there from analysts is $24+

User Image MoneyWise13 Posted - 1 week ago

$DAWN 👀👀 I smell the chefs in the kitchen prepping the main entree

User Image DonCorleone77 Posted - 1 week ago

$DAWN Day One Biopharmaceuticals management to meet with Piper Sandler Meetings to be held in Europe November 11-13 hosted by Piper Sandler.

User Image M_Chromatic Posted - 1 week ago

$DAWN Weekly chart with volume profile. Point-of-Control (orange horizontal line) is where the most volume has been traded and looks like strong support at $13.83. Above the current price there doesn't look like a lot of over head supply to stop a strong run if it makes one.

User Image NVDAMillionaire Posted - 1 week ago

$DAWN Day One Biopharmaceuticals (DAWN): Unlocking the Potential of Targeted Therapies for Life-Threatening Diseases https://beyondspx.com/article/day-one-biopharmaceuticals-dawn-unlocking-the-potential-of-targeted-therapies-for-life-threatening-diseases

User Image Doozio Posted - 1 week ago

$xbi is NOW in RYTM with $iwm from a new 🧠 $dawn 🧠👀 to da FUTUre of 🧠⏰ n $thrd INTA 🧠⏰♾️

User Image lolo14 Posted - 1 week ago

$DAWN PT upgrade JP Morgan 39$

User Image vatexas Posted - 1 week ago

$DAWN Bought few more here.. hoping for 20's soon

User Image TheGunnerAB Posted - 1 week ago

$DAWN $SWTX $IBRX $XFOR

User Image TheGunnerAB Posted - 1 week ago

$DAWN $SWTX $IBRX It looks like cancer treating companies are up. Everything else is down. M&A should pick up significantly, and approved cancer treating companies are the main target of BO.

User Image RonIsWrong Posted - 1 week ago

$DAWN continuation - elevated volume last few days

User Image Doozio Posted - 1 week ago

From a new 🧠 $dawn 🧠👀 to da FUTUre of 🧠⏰ INTA 🧠⏰♾️

User Image Magnificient Posted - 1 week ago

$DAWN good bo canidate. Only concern Ipsen Pattnership ex US?

User Image RonIsWrong Posted - 1 week ago

$DAWN highest close in more than three months.

User Image DonCorleone77 Posted - 1 week ago

$NXE $OPRA $GFL $MGNI $DAWN Ironically, today both GFL and DAWN are both trying to break of the bases I referenced in my post below. GFL chart is attached.

Analyst Ratings
JP Morgan Overweight Aug 6, 24
HC Wainwright & Co. Buy Aug 1, 24
B of A Securities Buy Aug 1, 24
Needham Buy Jul 31, 24
Needham Buy Jul 30, 24
HC Wainwright & Co. Buy Jul 26, 24
Piper Sandler Overweight Jul 8, 24
HC Wainwright & Co. Buy Jun 20, 24
Needham Buy Jun 19, 24
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
York Charles N II COO, CFO and Secreta.. COO, CFO and Secretary Nov 15 Sell 11.69 956 11,176 270,170 11/17/23
Dubow Adam General Counsel General Counsel Nov 15 Sell 11.69 5,313 62,109 11,428 11/17/23
Blackman Samuel C. Head of Research and.. Head of Research and Developme Nov 15 Sell 11.69 709 8,288 1,238,234 11/17/23
Bender Jeremy Chief Executive Offi.. Chief Executive Officer Nov 15 Sell 11.69 3,107 36,321 709,429 11/17/23
York Charles N II COO, CFO and Secreta.. COO, CFO and Secretary Aug 15 Sell 13.86 922 12,779 267,501 08/17/23
Blackman Samuel C. Head of Research and.. Head of Research and Developme Aug 15 Sell 13.86 668 9,258 1,236,319 08/17/23
Bender Jeremy Chief Executive Offi.. Chief Executive Officer Aug 15 Sell 13.86 2,996 41,525 704,224 08/17/23
Blackman Samuel C. Chief Medical Office.. Chief Medical Officer May 15 Sell 13.12 692 9,079 1,235,592 05/17/23
Bender Jeremy Chief Executive Offi.. Chief Executive Officer May 15 Sell 13.12 3,104 40,724 1,179,484 05/17/23
Blackman Samuel C. Chief Medical Office.. Chief Medical Officer Mar 10 Sell 18.0484 10,000 180,484 1,233,660 03/14/23
Bender Jeremy Chief Executive Offi.. Chief Executive Officer Mar 07 Sell 20.0091 12,500 250,114 1,174,276 03/08/23
York Charles N II COO, CFO and Secreta.. COO, CFO and Secretary Feb 17 Sell 20.0267 9,377 187,790 262,128 02/21/23
Blackman Samuel C. Chief Medical Office.. Chief Medical Officer Feb 15 Sell 19.57 674 13,190 1,243,660 02/17/23
Bender Jeremy Chief Executive Offi.. Chief Executive Officer Feb 15 Sell 19.57 3,022 59,141 1,186,776 02/17/23
Blackman Samuel C. Chief Medical Office.. Chief Medical Officer Feb 10 Sell 20.0659 10,000 200,659 1,241,710 02/13/23
York Charles N II COO, CFO and Secreta.. COO, CFO and Secretary Jan 20 Sell 22.7523 10,000 227,523 268,810 01/23/23
Blackman Samuel C. Chief Medical Office.. Chief Medical Officer Jan 10 Sell 22.98 10,000 229,800 1,250,148 01/11/23
Grant Julie Papanek Director Director Jan 03 Sell 20.83 25,000 520,750 380,000 01/04/23
York Charles N II COO, CFO and Secreta.. COO, CFO and Secretary Oct 03 Sell 20.0473 10,000 200,473 304,401 10/05/22
Grant Julie Papanek Director Director Oct 03 Sell 20.03 10,000 200,300 429,358 10/05/22
Grant Julie Papanek Director Director Sep 13 Sell 23.98 245,039 5,876,035 9,418,606 09/15/22
Canaan XI L.P. 10% Owner 10% Owner Sep 13 Sell 23.98 245,039 5,876,035 9,418,606 09/15/22
Grant Papanek Julie Director Director Sep 02 Sell 23.8215 5,000 119,108 439,358 09/15/22
York Charles N II COO, CFO and Secreta.. COO, CFO and Secretary Sep 01 Sell 23.48 10,000 234,800 314,401 09/06/22
Grant Papanek Julie Director Director Sep 01 Sell 23.5 5,000 117,500 444,358 09/06/22
Blackman Samuel C. Chief Medical Office.. Chief Medical Officer Sep 01 Sell 23.47 10,000 234,700 1,289,338 09/06/22
Bender Jeremy Chief Executive Offi.. Chief Executive Officer Sep 01 Sell 23.47 12,500 293,375 1,240,375 09/06/22
Blackman Samuel C. Chief Medical Office.. Chief Medical Officer Aug 15 Option 0 3,561 1,300,279 08/17/22
Blackman Samuel C. Chief Medical Office.. Chief Medical Officer Aug 15 Sell 24.31 941 22,876 1,299,338 08/17/22
Bender Jeremy Chief Executive Offi.. Chief Executive Officer Aug 15 Option 0 10,686 1,256,878 08/17/22
Bender Jeremy Chief Executive Offi.. Chief Executive Officer Aug 15 Sell 24.31 4,003 97,313 1,252,875 08/17/22
York Charles N II COO, CFO and Secreta.. COO, CFO and Secretary Aug 15 Option 0 4,125 325,490 08/17/22
York Charles N II COO, CFO and Secreta.. COO, CFO and Secretary Aug 15 Sell 24.31 1,089 26,474 324,401 08/17/22
Grant Papanek Julie Director Director Aug 04 Sell 20 10,000 200,000 449,358 08/08/22
York Charles N II COO, CFO and Secreta.. COO, CFO and Secretary Aug 04 Sell 20.0541 10,000 200,541 321,365 08/05/22
Bender Jeremy Chief Executive Offi.. Chief Executive Officer Aug 04 Sell 20.0017 12,500 250,021 1,246,192 08/05/22
Blackman Samuel C. Chief Medical Office.. Chief Medical Officer Aug 01 Sell 16.881 10,000 168,810 1,296,718 08/03/22
York Charles N II COO, CFO and Secreta.. COO, CFO and Secretary Jul 18 Sell 20.00 2,500 50,000 331,365 07/20/22
Grant Papanek Julie Director Director Jul 18 Sell 20.0004 2,600 52,001 459,358 07/20/22
Bender Jeremy Chief Executive Offi.. Chief Executive Officer Jul 18 Sell 20.0012 2,600 52,003 1,258,692 07/20/22
Grant Papanek Julie Director Director Jul 01 Sell 20 1,800 36,000 463,200 07/12/22
Grant Papanek Julie Director Director Jul 08 Sell 20.00 1,242 24,840 461,958 07/12/22
York Charles N II COO, CFO and Secreta.. COO, CFO and Secretary Jul 08 Sell 20.00 1,416 28,320 333,865 07/12/22
Bender Jeremy Chief Executive Offi.. Chief Executive Officer Jul 08 Sell 20.00 1,795 35,900 1,261,292 07/12/22
York Charles N II COO, CFO and Secreta.. COO, CFO and Secretary Jul 01 Sell 20 2,279 45,580 335,281 07/06/22
Blackman Samuel C. Chief Medical Office.. Chief Medical Officer Jul 01 Sell 19.14 10,000 191,400 1,306,718 07/06/22
Bender Jeremy Chief Executive Offi.. Chief Executive Officer Jul 01 Sell 20 2,603 52,060 1,263,087 07/06/22
Atlas Venture Opportunity Fund... 10% Owner 10% Owner Jun 17 Buy 15.00 766,667 11,500,005 766,667 06/22/22
Gladstone Michael Director Director Jun 17 Buy 15.00 766,667 11,500,005 766,667 06/22/22
Blackman Samuel C. Chief Medical Office.. Chief Medical Officer Jun 15 Sell 16.2631 50,000 813,155 1,316,718 06/17/22